Lista de obras -

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

artículo científico publicado en 2009

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

artículo científico publicado en 2014

Anxiety Disorders and Temperament-an Update Review

artículo científico publicado en 2017

Association between folate intake and melancholic depressive symptoms. A Finnish population-based study

artículo científico publicado en 2012

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

artículo científico publicado en 2013

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

artículo científico publicado en 2018

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

artículo científico publicado en 2013

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

artículo científico publicado en 2014

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

artículo científico publicado en 2010

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

scientific article published on 01 August 2004

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

artículo científico publicado en 2014

Factors associated with subjective side-effects during clozapine treatment

artículo científico publicado en 2014

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

artículo científico publicado en 2018

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

artículo científico publicado en 2017

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

artículo científico publicado en 2011

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

artículo científico publicado en 2010

Meta-analysis of anxiety disorders and temperament

artículo científico publicado en 2014

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

artículo científico publicado en 2013

One-year follow-up after discontinuing maintenance electroconvulsive therapy

artículo científico publicado en 2012

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

artículo científico publicado en 2011

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

artículo científico publicado en 2014

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

artículo científico publicado en 2011

Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year

artículo científico publicado en 2003

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

SERT and NET polymorphisms, temperament and antidepressant response

artículo científico publicado en 2015

Smoking and weight among patients using clozapine

artículo científico publicado en 2014

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

artículo científico publicado en 2009

TPH1 A218C polymorphism and temperament in major depression

artículo científico publicado en 2013

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

artículo científico publicado en 2009

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

artículo científico publicado en 2010

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

artículo científico publicado en 2010

[Diagnosis and drug therapy of anxiety disorders in primary health care]

artículo científico publicado en 2015

Lista de obras de

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

Anxiety Disorders and Temperament-an Update Review

Association between folate intake and melancholic depressive symptoms. A Finnish population-based study

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Factors associated with subjective side-effects during clozapine treatment

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

Meta-analysis of anxiety disorders and temperament

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

One-year follow-up after discontinuing maintenance electroconvulsive therapy

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

SERT and NET polymorphisms, temperament and antidepressant response

Smoking and weight among patients using clozapine

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

TPH1 A218C polymorphism and temperament in major depression

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

[Diagnosis and drug therapy of anxiety disorders in primary health care]